A 7-year-old boy developed a severe unilateral grand mal seizure at the age of 5 years (phenobarbitone therapy); 1.5 years later valproate (2-propylpentanoic acid, VPA) was added to the therapy.
severe unilateral grand mal seizure
phenobarbitone
severe unilateral grand mal seizure
VPA
severe unilateral grand mal seizure
2-propylpentanoic acid
severe unilateral grand mal seizure
valproate